Disopyramide detailed information: Difference between revisions
Jump to navigation
Jump to search
Matt Pijoan (talk | contribs) m Protected "Disopyramide detailed information": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)) |
m Bot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +) |
||
| Line 23: | Line 23: | ||
{{CMG}} | {{CMG}} | ||
Revision as of 00:50, 9 August 2012
 | |
| Clinical data | |
|---|---|
| Pregnancy category | |
| Routes of administration | Oral, intravenous |
| ATC code | |
| Legal status | |
| Legal status | |
| Pharmacokinetic data | |
| Bioavailability | High |
| Protein binding | 50% to 65% (concentration-dependent) |
| Metabolism | Hepatic (CYP3A4-mediated) |
| Elimination half-life | 6.7 hours (range 4 to 10 hours) |
| Excretion | Renal (80%) |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| E number | {{#property:P628}} |
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C21H29N3O |
| Molar mass | 339.475 g/mol |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
For patient information, click here
Overview
Disopyramide (INN, trade names Norpace® and Rythmodan®) is an antiarrhythmic medication. It is a Class Ia antiarrythmic used in the treatment of ventricular tachycardias. It has no effect on alpha or beta adrenergic receptors.
External links
Template:Antiarrhythmic agents